Northrop Clinches Deal to Support E-2D Advanced Hawkeye Jets
Details of NOC's Deal
Per the terms of the deal, Northrop will provide support for integrating production attrition capabilities, including updates to software and hardware throughout their life cycle. It covers a wide range of tasks, such as design, programming, integration, manufacturing, quality checks and testing, for the E-2D Advanced Hawkeye aircraft, with varying levels of effort over time.
Valued at nearly $46.7 million, the contract is anticipated to be completed by May 2029. The work related to this contract will be executed in multiple locations across the United States.
What Lies Next for NOC Stock?
Rising military conflicts, terrorism and border disputes, along with rapid technological advancements in combat jets, have led nations to increase their defense spending on combat-proven jets, which constitute an integral part of their defense structure.
This is likely to have prompted the Mordor Intelligence firm to forecast a compound annual growth rate of 4.7% for the global military aviation market during the 2025-2030 period.
Such growth prospects should benefit Northrop, which has been a pioneer in the development of manned aircraft. The company's product line includes a wide range of defense aircraft like E-2C Hawkeye 2000, E-130J TACAMO, F-5 Tiger and B-2 Spirit Stealth.
In particular, Northrop's E-2D Advanced Hawkeye aircraft provides combat management, air and missile defense, and multiple sensor fusion capabilities in an airborne system. These offer the warfighter greater battlespace awareness, particularly in the domain of information operations.
These features of the E-2D Advanced Hawkeye jets must have been boosting its demand, ushering in solid order flows, like the latest contract win, and in the future, should continue to steadily contribute to NOC's revenue growth.
Opportunities for Other Aerospace Stocks
Other aerospace companies that are likely to benefit from the expanding global military aviation market are discussed below:
The Boeing Company BA: The company offers a comprehensive portfolio of the most advanced aircraft in the combat market, which includes F/A-18 Super Hornet, F-15EX, CH-47 Chinook, Chinook Block II and EA-18G Growler.
Boeing boasts a long-term (three to five years) earnings growth rate of 18.1%. The Zacks Consensus Estimate for BA's 2025 sales suggests an improvement of 25.6%.
Lockheed Martin Corp. LMT: The company is among the leaders in the combat aircraft space, with its product portfolio constituting some of the most advanced military aircraft, such as the F-35 Lightning II, F-21, F-22 Raptor and F-16 Fighting Falcon.
Lockheed boasts a long-term earnings growth rate of 10.5%. The Zacks Consensus Estimate for LMT's 2025 sales implies an improvement of 4.7%.
Embraer S.A. ERJ: The company offers a comprehensive portfolio of the most advanced aircraft in the combat market, which includes the A-29 Super Tucano, P600 AEW&C and the C-390 Millennium military multi-mission aircraft.
The Zacks Consensus Estimate for ERJ's 2025 sales indicates growth of 15.4%. The company delivered an average earnings surprise of 150.60% in the last four quarters.
NOC Stock Price Movement
In the past month, Northrop shares have risen 4% compared with the industry 's growth of 2.8%.
NOC's Zacks Rank
Northrop currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Higher. Faster. Sooner. Buy These Stocks Now
A small number of stocks are primed for a breakout, and you have a chance to get in before they take off.
At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We've combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.
You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.
Download the report free now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Boeing Company (BA): Free Stock Analysis Report
Lockheed Martin Corporation (LMT): Free Stock Analysis Report
Northrop Grumman Corporation (NOC): Free Stock Analysis Report
Embraer-Empresa Brasileira de Aeronautica (ERJ): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
18 hours ago
- Globe and Mail
3 Integrated Energy Stocks to Gain Despite Industry Vulnerability
The crude oil pricing environment is expected to experience significant volatility this year, which will negatively impact the exploration and production activities of integrated energy companies. A deceleration in oil production growth can create challenges, thereby constraining earnings from upstream operations. At the same time, the accelerating shift toward renewable energy is introducing greater uncertainty to the Zacks Oil and Gas Integrated International industry's prospects. This combination of factors suggests a challenging and softened industry environment that is expected to persist through at least the remainder of 2025. Among the companies in the industry that will probably survive the business challenges are Exxon Mobil Corporation XOM, Chevron Corporation CVX and Shell plc SHEL. About the Industry The Zacks Oil and Gas Integrated International industry covers companies primarily involved in upstream, midstream and downstream operations. These companies have upstream businesses in the United States (including prolific shale plays and the deepwater Gulf of Mexico), Asia, South America, Africa, Australia and Europe. Midstream operations of energy companies entail transporting oil, natural gas liquids and refined petroleum products. In downstream businesses, the firms buy raw crude to produce refined petroleum products. The companies' downstream activities involve chemical businesses that manufacture raw materials for making plastics. The integrated players are now gradually focusing on renewables, leading to the energy transition. The firms aim to lower emissions from operations and cut the carbon intensity of the products sold. 3 Trends Shaping the Future of the Industry Macroeconomic Volatility: The integrated energy sector is currently navigating a highly uncertain and challenging macroeconomic environment. Refining, renewable energy and chemical segments are particularly under pressure due to limited visibility into future market dynamics. Escalating trade tensions are compounding this uncertainty, raising concerns over potential economic slowdowns. Meanwhile, oil prices remain volatile, swayed by geopolitical risks and fluctuating OPEC+ production strategies. As a result, major integrated energy players are grappling with profitability challenges. Slowdown in Production Growth to Hurt Upstream Business: There has been a slowdown in oil production growth in the upstream businesses of integrated energy companies in the United States due to shareholder demands for a greater focus on returning capital rather than investing in production expansion. As production growth slows, output decreases, which can lead to reduced revenues. Since upstream operations depend heavily on volume to generate income, any stagnation in production growth has a direct and negative impact on their bottom line. Growing Demand for Renewables is Concerning: Governments, investors and stakeholders are placing growing emphasis on addressing climate change, leading to an increased demand for renewable energy. Consequently, the demand for products reliant on oil, natural gas and natural gas liquids is expected to decline, with solar and wind energy gaining prominence in the energy landscape. The integrated energy firms are adversely impacted by these trends as they are primarily engaged in the production and transportation of fossil fuels, such as oil, and the sale of refined petroleum products. Zacks Industry Rank Indicates Bearish Outlook The Zacks Oil and Gas Integrated International industry is part of the broader Zacks Oil - Energy sector. It carries a Zacks Industry Rank #189, which places it in the bottom 23% of the 245 Zacks industries. The group's Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates bleak near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Before we present a few stocks that you may want to consider, let us take a look at the industry's recent stock market performance and valuation picture. Industry Lags S&P 500 & Sector The Zacks Oil and Gas Integrated International industry has underperformed the broader Zacks Oil - Energy sector and the Zacks S&P 500 composite over the past year. The industry has plunged 5.4% over this period compared with the S&P 500's growth of 17.3% and the broader sector's decline of 2.6%. One-Year Price Performance Industry's Current Valuation Since oil and gas companies are debt-laden, it makes sense to value them based on the Enterprise Value/Earnings before Interest Tax Depreciation and Amortization (EV/EBITDA) ratio. This is because the valuation metric takes not just equity into account but also the level of debt. On the basis of the trailing 12-month EV/EBITDA, the industry is currently trading at 4.27X, lower than the S&P 500's 17.85X. It is also below the sector's trailing 12-month EV/EBITDA of 4.77X. Over the past five years, the industry has traded as high as 6.54X and as low as 2.75X, with a median of 4.11X. Trailing 12-Month Enterprise Value-to EBITDA (EV/EBITDA) Ratio 3 Integrated International Stocks to Watch Chevron: The company completed its $53-billion acquisition of Hess Corporation, thereby strengthening its upstream portfolio and obtaining a 30% interest in the highly valued Stabroek Block offshore Guyana. Chevron gains strategic access to one of the most prolific deepwater discoveries of the past decade, estimated to hold more than 11 billion barrels of recoverable oil. The acquisition also strengthens its position in the U.S. Bakken shale, the Gulf of Mexico and Southeast Asia. It currently carries a Zacks Rank #3 (Hold). The move comes as a turning point for Chevron as it is facing mounting pressure to replenish its reserves and strengthen free cash flow amid ongoing volatility in the oil markets. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Price and Consensus: CVX ExxonMobil: The company's acquisition of Pioneer Natural Resources expanded its production capabilities in the Permian Basin, one of the most profitable regions in the United States due to its inexpensive production costs. XOM boasts a strong portfolio of upstream assets, focused on oil-rich resources in the Permian Basin and offshore Guyana. Production costs in those assets are low. Therefore, the leading integrated energy major can overcome a collapse in oil and gas prices. Similar to its operations in the Permian, ExxonMobil boasts a robust project pipeline in offshore Guyana resources. It presently carries a Zacks Rank #3. Price and Consensus: XOM Shell: The company's acquisition of Pavilion Energy strengthens its LNG trading capabilities and positions itself for long-term growth in cleaner fuels. Shell's position as a major supplier of LNG should help the company meet the fuel's growing demand and improve its cash flow. Shell, with a Zacks Rank of 3, is targeting a 4-5% annual increase in LNG sales over the next five years and 1% annual production growth. Price and Consensus: SHEL 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exxon Mobil Corporation (XOM): Free Stock Analysis Report Chevron Corporation (CVX): Free Stock Analysis Report
Globe and Mail
20 hours ago
- Globe and Mail
Morgan Stanley Wealth Management Delivers New Tool to Help Clients Tackle Single Stock Risk
Morgan Stanley Wealth Management's Global Investment Office (GIO) has launched the Equity Vulnerability Score, a proprietary tool that can help clients and the Financial Advisors who serve them measure and rank the susceptibility of US stocks to potential future drops in value. As a risk management tool, this can help provide important insights for investors—especially those who hold concentrated equity positions, which Morgan Stanley defines as five or fewer stocks making up more than 30% of the risk in a portfolio. Concentrated equity positions often occur naturally for company founders, those who receive equity compensation, and early investors. As these positions grow over time, they can unwittingly expose the investor to underperformance, higher volatility and material drawdowns—when a stock begins to decline from its peak and can drag the rest of the investor's portfolio down with it. Looking historically, the GIO found that among the individual stocks contained in the Russell 1000 Index, a stock market index that represents the 1000 top companies by market capitalization in the United States: Individual stocks were more than twice as volatile as the index itself (37% v. 15%) since 2014 The average stock's maximum drawdown was twice as large as the index's (approximately 50% vs. 25%) Most individual stocks tend to underperform the index on any forward-looking basis, with the median underperformance clocking in at -2.6% per year Most stocks that outperformed the index over five years went on to then underperform in the following five years 1 The Equity Vulnerability Score can help flag the likelihood that a stock may soon drop in value, and can also be used to complement Morgan Stanley's existing Tactical Equity Framework, which helps identify short-term opportunities to seek overall stronger performance. 'As a leader in both equity compensation and in providing guidance to founders, early-stage investors, and executives of publicly traded companies, we see this is a significant and often overlooked challenge for many of the clients our Advisors serve,' said Steve Edwards, Senior Investment Strategist, Morgan Stanley Wealth Management. 'And while it is natural to have an emotional attachment to a stock that you've watched grow over time, it can also pose an outsized risk. Morgan Stanley Wealth Management has been unwavering in helping to address this issue, and the vulnerability score puts another arrow in our quiver to continue to do just that.' The Equity Vulnerability Score draws from a broad range of indicators proven to have a strong correlation with the negative returns brought on by drawdowns, in three main categories: Financial Stability – Looks at the stability of a company's finances by comparing key metrics such as earnings or revenue, as well as how much those numbers fluctuate over time. Fundamental Momentum – Checks whether a company's important financial numbers are improving or declining, using key gauges of profitability, quality, and value. Volatility and Tail Risk – Measures recent stock price moves, focusing on large drops and trading activity. For more information, please find the following report: Global Investment Committee Special Report: Confronting the Concentrated Equity Challenge and Measuring Drawdown Vulnerability. See also: About Morgan Stanley Wealth Management Morgan Stanley Wealth Management is a leading financial services firm that provides access to a wide range of products and services to individuals, businesses, and institutions, including brokerage and investment advisory services, financial and wealth planning, cash management and lending products and services, annuities and insurance, retirement, and trust services. About Morgan Stanley Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit A decline in the value of the investments held in a concentrated portfolio of a limited number of securities would cause the portfolio's overall value to decline to a greater degree than that of a less concentrated portfolio. Morgan Stanley's Equity Vulnerability Score is a quantitative factor-based ranking of US stocks' relative vulnerability to future drawdowns. To compute the Equity Vulnerability Score, a set of three differentiated factor categories were selected: (1) the Financial Stability category, (2) the Fundamental Momentum category, and (3) the Volatility and Tail Risk category. After combining the scores for the underlying indicators therein to derive the three categories-level scores, the categories' conclusions are then blended into the overall Equity Vulnerability Score. Consistent with Morgan Stanley's Tactical Equity Framework, the Equity Vulnerability Score relied primarily on FactSet's Quant Factor Library (QFL) dataset. © 2025 Morgan Stanley Smith Barney LLC. Member SIPC
Globe and Mail
20 hours ago
- Globe and Mail
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
International expansion continues to play a central role in Hologic 's HOLX growth strategy. Currently, it generates around 25% of its total revenues from outside the United States — a lower proportion compared to other medical technology companies. Over the past decade, the company has made targeted investments toward international expansion and commercial capabilities, which have delivered more than 10% international growth annually. Even so, the underpenetration presents significant room for expansion. While many of Hologic's product successes began in the United States, it has now built the capabilities to scale internationally on a consistent basis. In its Surgical division, the company continues to invest organically, especially in the International business, where it has delivered more than 20% growth for several years. The momentum is supported by increased reimbursement and the promotion of guidelines for its portfolio of product offerings. In the fiscal second quarter of 2025, the International Surgical business rose 16.2% year over year. MyoSure is seeing even faster gains abroad, fueled by vastly untapped markets and higher demand for minimally invasive options to treat uterine polyps and fibroids. Newly acquired Gynesonics gave a boost, having already generated a healthy mix of international sales before joining Hologic. Now with the support of Hologic's large Gyn sales force, Gynesonics' sales are expected to grow at a strong double-digit rate. NovaSure is also seeing higher sales volume in Europe despite posting domestic declines. That said, global exposure brings added operational challenges. The company's second-quarter international sales were hurt by the ongoing physician strike in South Korea, reduced hospital spending in China and lower HIV testing sales in Africa due to USAID funding cuts. In China, Hologic's cytology business is now weighed down by tariff implications, anti-American sentiment and intensifying local competition. International Performance of Hologic's Top Rivals Becton, Dickinson and Company BDX, or BD, derives a significant portion of its revenues from overseas, with products being distributed either directly or through independent distribution channels and sales representatives. In the second quarter of 2025, BD's international revenues increased 1.2%, driven by gains in the Medical segment's Pharmaceutical Systems unit and the acquired Advanced Patient Monitoring unit's sales. Based on tariffs in effect as of April 30, 2025, BD anticipates a $90 million hit to fiscal year 2025 operating expenses. Abbott ABT, too, maintains a strong global footprint, with sales outside the United States accounting for approximately 61% of its 2024 net sales. In the second quarter of 2025, international sales increased 6.6% year over year. Abbott remains the global leader in adult nutrition, supported by continued demand for its Ensure and Glucerna brands. ABT's Electrophysiology division also drove strong performance across 15 key markets — including India, China, and other markets across Asia, Latin America and the Middle East — representing some of the most attractive growth areas for branded generic medicines. HOLX Stock Performance, Valuation and Estimates Year to date, Hologic shares have declined 8.5% compared with the industry's 10.2% fall. Image Source: Zacks Investment Research Hologic is trading at a forward five-year price-to-earnings of 14.84X, lower than the industry average of 28.28X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research Consensus estimates for Hologic's fiscal 2025 EPS are showing a downward trend for the past 90 days. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Becton, Dickinson and Company (BDX): Free Stock Analysis Report Hologic, Inc. (HOLX): Free Stock Analysis Report
